{
  "actions": [
    {
      "acted_at": "2017-03-29", 
      "action_code": "Intro-H", 
      "references": [], 
      "text": "Introduced in House", 
      "type": "action"
    }, 
    {
      "acted_at": "2017-03-29", 
      "action_code": "H11100-A", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2017-03-29", 
      "action_code": "H11100", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "text": "Referred to House Energy and Commerce", 
      "type": "referral"
    }, 
    {
      "acted_at": "2017-03-29", 
      "action_code": "H11100", 
      "committees": [
        "HSWM"
      ], 
      "references": [], 
      "text": "Referred to House Ways and Means", 
      "type": "referral"
    }, 
    {
      "acted_at": "2017-03-31", 
      "action_code": "", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2017-04-05", 
      "action_code": "", 
      "committees": [
        "HSWM"
      ], 
      "references": [], 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr1775-115", 
  "bill_type": "hr", 
  "by_request": false, 
  "committee_reports": [], 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Ways and Means", 
      "committee_id": "HSWM"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Ways and Means", 
      "committee_id": "HSWM", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "02"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "14"
    }
  ], 
  "congress": "115", 
  "cosponsors": [
    {
      "bioguide_id": "C000714", 
      "district": "13", 
      "name": "Conyers, John, Jr.", 
      "original_cosponsor": true, 
      "sponsored_at": "2017-03-29", 
      "state": "MI", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2017-03-29", 
  "number": "1775", 
  "official_title": "To amend part D of title XVIII of the Social Security Act to direct the President to negotiate prescription drug prices and establish a formulary on behalf of Medicare beneficiaries, and for other purposes.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "s1688-115", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }
  ], 
  "short_title": "Prescription Reduction in Costs for Everyone (PRICE) Act of 2017", 
  "sponsor": {
    "bioguide_id": "D000191", 
    "district": "4", 
    "name": "DeFazio, Peter A.", 
    "state": "OR", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2017-03-29", 
  "subjects": [
    "Health", 
    "Medicare", 
    "Prescription drugs", 
    "Presidents and presidential powers, Vice Presidents", 
    "Public contracts and procurement"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced in House", 
    "date": "2017-03-29T04:00:00Z", 
    "text": "Prescription Reduction in Costs for Everyone (PRICE) Act of 2017\n\nThis bill amends title XVIII (Medicare) of the Social Security Act to require the President, with respect to offering one or more Medicare-operated prescription drug plan options, to: (1) negotiate prices\u00a0with drug manufacturers, and (2) establish and apply a formulary and formulary incentives. In general, a Medicare-operated drug plan must meet the same requirements as apply to other prescription drug plans.\n\nThe President must report to Congress biannually on negotiations conducted by the President to achieve lower prices for Medicare beneficiaries."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Prescription Reduction in Costs for Everyone (PRICE) Act of 2017", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Prescription Reduction in Costs for Everyone (PRICE) Act of 2017", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To amend part D of title XVIII of the Social Security Act to direct the President to negotiate prescription drug prices and establish a formulary on behalf of Medicare beneficiaries, and for other purposes.", 
      "type": "official"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "Prescription Reduction in Costs for Everyone (PRICE) Act of 2017", 
      "type": "display"
    }
  ], 
  "updated_at": "2017-09-11T03:02:57Z", 
  "url": "https://www.gpo.gov/fdsys/bulkdata/BILLSTATUS/115/hr/BILLSTATUS-115hr1775.xml"
}